Beyond antigens and adjuvants: formulating future vaccines

Area of Science:

• Immunology
• Vaccinology
• Nanotechnology

Background:

• Optimizing vaccine potency and minimizing toxicity is crucial for effective immunization.
• Subunit vaccines require efficient trafficking to lymph nodes (LNs), immune cell activation, and sustained presence for a mature response.

Purpose of the Study:

• To review formulation strategies for tailoring vaccine function: antigen/adjuvant delivery, immune cell activation, and immune response kinetics.
• To explore how optimized formulations can enhance vaccine potency and safety.

Main Methods:

• Review of traditional vaccine adjuvants and their mechanisms.
• Analysis of nanoparticle and lymphatic-targeting strategies for direct LN delivery.
• Examination of formulation approaches to regulate biodistribution and antigen/adjuvant co-uptake.
• Discussion of strategies to program vaccine kinetics through novel delivery systems.

Main Results:

• Traditional adjuvants promote antigen transport and retention in LNs.
• Direct targeting of antigens and adjuvants to LNs via nanoparticles enhances potency without compromising safety.
• Formulations can regulate biodistribution and co-uptake of immune cues.
• Novel delivery strategies can program vaccine kinetics to boost immune responses.

Conclusions:

• Optimized vaccine formulations are key to enhancing efficacy and safety.
• Tailoring antigen and adjuvant delivery to LNs and controlling immune response kinetics are promising strategies.
• These formulation technologies pave the way for next-generation vaccines with improved performance and safety profiles.